Evozyne operates a molecular engineering platform that leverages data-driven evolution methods to create novel proteins with enhanced functionalities. Their technology focuses on modeling proteins, understanding protein folding and function, and the development of synthetic proteins
Mike Gamson Chief Executive Officer |
Zach Serber Ph.D Chief Operating Officer |
Aris Theologis Chief Business Officer |
Uri Herzberg Ph.D Chief Drug Discover Officer |
Rama Ranganathan Ph.D Co-Founder & Chief Strategic Officer |